ChanBio

Biopharmaceuticals for Treatment of Multiple Sclerosis

Health Tech & Life Sciences
Non Active, Dec 2016
Seed Yavne, Israel Founded 2012
Last updated 2026-06-18
Total raised
Last: 2013-11
Stage
Seed
Founded
2012
Headcount
6
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences

About

ChanBio is a biopharmaceutical company dedicated to the development of functional antibody-based modulators active on ion channels and G-protein-coupled receptors (GPCRs). The company is developing treatments for multiple sclerosis as well as other autoimmune, cardiovascular, cancer-related, and pain disorders. ChanBio operates out of the Merck Serono Israel, the Bioincubator of Merck Inc.

Funding history · 2 rounds · — total

2013-11
Undisclosed
2013-01
Undisclosed

Q&A

What is ChanBio's primary focus?
ChanBio is a biopharmaceutical company focused on developing functional antibody-based modulators for ion channels and G-protein-coupled receptors (GPCRs), with treatments for multiple sclerosis, autoimmune, cardiovascular, cancer-related, and pain disorders.
When was ChanBio founded?
ChanBio was founded in January 2012.
What is ChanBio's current operational status?
ChanBio is currently inactive, as of December 2016.
Where is ChanBio's headquarters located?
ChanBio's headquarters is located in Yavne, Center District, Israel.
Who are the investors in ChanBio's funding rounds?
ChanBio received investments from Merck Group in January 2013 and M Ventures in November 2013.
What is ChanBio's current product stage?
ChanBio's product is in the R&D stage.
Does ChanBio hold any patents?
Yes, ChanBio holds one patent.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

canceroncologybiopharmaceuticalcardiovascularpharmaceuticalsbiotechnologychronic-painantibodiescardiologytreatmentsautoimmune-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2012-1
Employees (exact)6
Status reasonNon Active, Dec 2016